Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trialMallinckrodt and Novoteris have been given a green light by Health Canada to start a pilot study of Share XMallinckrodt, Novoteris’ nitric oxide will start COVID-19 trialhttps://pharmaphorum.com/news/mallinckrodt-novoteris-nitric-oxide-will-start-covid-19-trial/
